Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

61 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of low-dose aspirin on primary prevention of cardiovascular events in Japanese diabetic patients at high risk.
Okada S, Morimoto T, Ogawa H, Sakuma M, Soejima H, Nakayama M, Sugiyama S, Jinnouchi H, Waki M, Doi N, Horii M, Kawata H, Somekawa S, Soeda T, Uemura S, Saito Y; investigators for the Japanese Primary Prevention of Atherosclerosis with Aspirin for Diabetes (JPAD) trial. Okada S, et al. Among authors: somekawa s. Circ J. 2013;77(12):3023-8. doi: 10.1253/circj.cj-13-0307. Epub 2013 Sep 13. Circ J. 2013. PMID: 24042256 Free article. Clinical Trial.
Intensive lipid-lowering therapy with rosuvastatin stabilizes lipid-rich coronary plaques. -Evaluation using dual-source computed tomography.-.
Soeda T, Uemura S, Okayama S, Kawakami R, Sugawara Y, Nakagawa H, Matsumoto T, Sung JH, Nishida T, Senoo A, Somekawa S, Takeda Y, Ishigami K, Kawata H, Horii M, Saito Y. Soeda T, et al. Among authors: somekawa s. Circ J. 2011;75(11):2621-7. doi: 10.1253/circj.cj-11-0139. Epub 2011 Aug 6. Circ J. 2011. PMID: 21821963 Free article. Clinical Trial.
Treatment with recombinant placental growth factor (PlGF) enhances both angiogenesis and arteriogenesis and improves survival after myocardial infarction.
Takeda Y, Uemura S, Iwama H, Imagawa K, Nishida T, Onoue K, Takemoto Y, Soeda T, Okayama S, Somekawa S, Ishigami K, Takaoka M, Kawata H, Kubo A, Horii M, Nakajima T, Saito Y. Takeda Y, et al. Among authors: somekawa s. Circ J. 2009 Sep;73(9):1674-82. doi: 10.1253/circj.cj-08-1067. Epub 2009 Jul 15. Circ J. 2009. PMID: 19602778 Free article.
Reduction of circulating soluble fms-like tyrosine kinase-1 plays a significant role in renal dysfunction-associated aggravation of atherosclerosis.
Onoue K, Uemura S, Takeda Y, Somekawa S, Iwama H, Imagawa K, Nishida T, Morikawa Y, Takemoto Y, Asai O, Soeda T, Okayama S, Ishigami K, Nakatani K, Kawata H, Horii M, Nakajima T, Akai Y, Iwano M, Saito Y. Onoue K, et al. Among authors: somekawa s. Circulation. 2009 Dec 15;120(24):2470-7. doi: 10.1161/CIRCULATIONAHA.109.867929. Circulation. 2009. PMID: 19948974
Prognostic value of B-type natriuretic peptide and its amino-terminal proBNP fragment for cardiovascular events with stratification by renal function.
Horii M, Matsumoto T, Uemura S, Sugawara Y, Takitsume A, Ueda T, Nakagawa H, Nishida T, Soeda T, Okayama S, Somekawa S, Ishigami K, Takeda Y, Kawata H, Kawakami R, Saito Y. Horii M, et al. Among authors: somekawa s. J Cardiol. 2013 Jun;61(6):410-6. doi: 10.1016/j.jjcc.2013.01.015. Epub 2013 Apr 22. J Cardiol. 2013. PMID: 23618914 Free article.
An elevated ratio of placental growth factor to soluble fms-like tyrosine kinase-1 predicts adverse outcomes in patients with stable coronary artery disease.
Matsumoto T, Uemura S, Takeda Y, Matsui M, Okada S, Nishida T, Soeda T, Okayama S, Somekawa S, Ishigami K, Onoue K, Kawata H, Kawakami R, Horii M, Saito Y. Matsumoto T, et al. Among authors: somekawa s. Intern Med. 2013;52(10):1019-27. doi: 10.2169/internalmedicine.52.9073. Epub 2013 May 15. Intern Med. 2013. PMID: 23676585 Free article. Clinical Trial.
61 results